JESUS MORENO: Open Payments
NPI 1033779590 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 23 payments from 13 companies in 2025. Trend: 2023 $609 · 2024 $3,279 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 3 | $176 |
| AstraZeneca Pharmaceuticals LP | 4 | $144 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Gilead Sciences, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 1 | $34 |
| Theratechnologies Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Grifols USA, LLC | 1 | $29 |
| JAZZ PHARMACEUTICALS INC. | 1 | $28 |
Products named: CABENUVA, AIRSUPRA, TRELEGY ELLIPTA, GLASSIA, FASENRA, APRETUDE, PURIFIED CORTROPHIN GEL, EGRIFTA.
Industry payments across FL — which companies pay providers there.
